These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 19264221)

  • 1. DRCR Study: outcomes in focal vs diffuse edema?
    Blanco-Garavito R; Rodriguez-Valdes PJ
    Ophthalmology; 2009 Mar; 116(3):595-6; author reply 596-7. PubMed ID: 19264221
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetic macular edema.
    Jonas J; Rensch F
    Ophthalmology; 2009 Mar; 116(3):594-5; author reply 596-7. PubMed ID: 19264219
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetic macular edema.
    Narula R; Agarwal M; Chaudhary SP; Shroff C
    Ophthalmology; 2009 Sep; 116(9):1833-4; author reply 1834. PubMed ID: 19729104
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetic macular edema.
    Gillies M
    Ophthalmology; 2009 Mar; 116(3):595; author reply 596-7. PubMed ID: 19264220
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetic macular edema.
    Kim SJ
    Ophthalmology; 2009 Jun; 116(6):1228.e1; author reply 1228-9. PubMed ID: 19486803
    [No Abstract]   [Full Text] [Related]  

  • 6. Correspondence.
    Lorenzo-Carrero J
    Retina; 2009 Jun; 29(6):868-9; author reply 869. PubMed ID: 19516126
    [No Abstract]   [Full Text] [Related]  

  • 7. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
    Er H
    Am J Ophthalmol; 2008 Aug; 146(2):332-3; author reply 333. PubMed ID: 18656589
    [No Abstract]   [Full Text] [Related]  

  • 8. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
    Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
    Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.
    Diabetic Retinopathy Clinical Research Network
    Ophthalmology; 2008 Sep; 115(9):1447-9, 1449.e1-10. PubMed ID: 18662829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.
    Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Liu DT; Li KK; Li PS; Shanmugam MP
    Ophthalmology; 2007 Dec; 114(12):2162-7. PubMed ID: 17459479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macular edema treatment.
    Salti HI; Khoury J; Khairallah N; Hamam R
    Ophthalmology; 2006 May; 113(5):885; author reply 885-6. PubMed ID: 16650688
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravitreal triamcinolone prior to laser treatment of diabetic macular edema: 24-month results of a randomized controlled trial.
    Gillies MC; McAllister IL; Zhu M; Wong W; Louis D; Arnold JJ; Wong TY
    Ophthalmology; 2011 May; 118(5):866-72. PubMed ID: 21232801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterior sub-Tenon's capsule triamcinolone injection combined with focal laser photocoagulation for diabetic macular edema.
    Tunc M; Onder HI; Kaya M
    Ophthalmology; 2005 Jun; 112(6):1086-91. PubMed ID: 15885789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
    Kang SW; Park SC; Cho HY; Kang JH
    Am J Ophthalmol; 2007 Dec; 144(6):878-885. PubMed ID: 17936715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal cortisone injection for refractory diffuse diabetic macular edema.
    Ho TC; Lai WW
    Ophthalmologica; 2006; 220(5):349-50; author reply 350. PubMed ID: 16954717
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravitreal triamcinolone acetonide as an adjuvant therapy to panretinal photocoagulation for proliferative retinopathy with high risk characteristics in type 1 diabetes: case report with 22 weeks follow-up.
    Kytö JP; Angerman S; Lumiste E; Paloheimo M; Summanen PA
    Acta Ophthalmol Scand; 2005 Oct; 83(5):605-8. PubMed ID: 16188001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study.
    ; Chew E; Strauber S; Beck R; Aiello LP; Antoszyk A; Bressler N; Browning D; Danis R; Fan J; Flaxel C; Friedman S; Glassman A; Kollman C; Lazarus H
    Ophthalmology; 2007 Jun; 114(6):1190-6. PubMed ID: 17544778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
    ; Elman MJ; Aiello LP; Beck RW; Bressler NM; Bressler SB; Edwards AR; Ferris FL; Friedman SM; Glassman AR; Miller KM; Scott IU; Stockdale CR; Sun JK
    Ophthalmology; 2010 Jun; 117(6):1064-1077.e35. PubMed ID: 20427088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema.
    ; Beck RW; Edwards AR; Aiello LP; Bressler NM; Ferris F; Glassman AR; Hartnett E; Ip MS; Kim JE; Kollman C
    Arch Ophthalmol; 2009 Mar; 127(3):245-51. PubMed ID: 19273785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macular grid photocoagulation after intravitreal triamcinolone acetonide for diffuse diabetic macular edema.
    Kang SW; Sa HS; Cho HY; Kim JI
    Arch Ophthalmol; 2006 May; 124(5):653-8. PubMed ID: 16682586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.